Search

everythinglearnresearchcommunity

for

Search:↓

A new compound shows promise as a topical treatment for hair loss.

Erlotinib may cause scarring hair loss.

Baicalin may help treat severe drug-induced skin reactions.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Erlotinib can cause persistent excessive hair growth.

Early diagnosis and comprehensive management improve life quality for Netherton syndrome patients.

Bempikibart may help regrow hair in people with alopecia areata.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Cepharanthine shows promise as a natural anticancer treatment.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Aminopterin strongly suppresses epithelial tissues and can treat certain skin conditions but has significant side effects.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Lower doses of topotecan are safe for eyes, but higher doses may harm the retina.

Topical ruxolitinib quickly improves non-segmental vitiligo.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

EGFR inhibitors for lung cancer can cause severe skin issues.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.